| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0008 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.001 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.002 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.003 |